TSE:4934

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Premier Anti-Aging

Market Cap

JP¥117.0b

Last Updated

2021/06/17 08:08 UTC

Data Sources

Company Financials

Executive Summary

Premier Anti-Aging Co., Ltd. engages in the planning, development, import/export, mail order, wholesale, and retail business of cosmetics and health foods. More Details


Snowflake Analysis

Weak fundamentals or lack of information.

Share Price & News

How has Premier Anti-Aging's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: 4934 is more volatile than 90% of JP stocks over the past 3 months, typically moving +/- 10% a week.

Volatility Over Time: 4934's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of JP stocks.


Market Performance


7 Day Return

-14.8%

4934

1.3%

JP Personal Products

0.4%

JP Market


1 Year Return

n/a

4934

2.0%

JP Personal Products

22.6%

JP Market

Return vs Industry: Insufficient data to determine how 4934 performed against the JP Personal Products industry.

Return vs Market: Insufficient data to determine how 4934 performed against the JP Market.


Shareholder returns

4934IndustryMarket
7 Day-14.8%1.3%0.4%
30 Day7.4%5.4%3.6%
90 Day24.5%-0.7%-2.3%
1 Yearn/a3.3%2.0%25.3%22.6%
3 Yearn/a-15.1%-18.2%20.3%12.1%
5 Yearn/a88.8%76.3%78.4%58.9%

Long-Term Price Volatility Vs. Market

How volatile is Premier Anti-Aging's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Premier Anti-Aging undervalued compared to its fair value and its price relative to the market?


In this section, we usually try to help investors determine whether Premier Anti-Aging is trading at an attractive price based on the cash flow it is expected to produce in the future. But as Premier Anti-Aging has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Future Growth

How is Premier Anti-Aging forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

17.8%

Forecasted Household industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Premier Anti-Aging has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Premier Anti-Aging performed over the past 5 years?

0.6%

Historical Household annual earnings growth


In this section we usually display a company’s past earnings and revenues to help investors visualise the trend through time. We also gauge the company’s performance by benchmarking its returns and growth to its industry peers and the wider market. However, Premier Anti-Aging has not provided sufficient past data to assess its track record.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have historical data.


Financial Health

How is Premier Anti-Aging's financial position?


In this section we usually analyse Premier Anti-Aging's finance health to determine how well-positioned it is against times of financial distress, in particular, its ability to manage its cash and debt levels. Premier Anti-Aging has not provided adequate balance sheet data, its financial health cannot be properly assessed as it.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have financial information.


Dividend

What is Premier Anti-Aging current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate 4934's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate 4934's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if 4934's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if 4934's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of 4934's dividend in 3 years as they are not forecast to pay a notable one for the JP market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?


CEO

Kiyoshi Matsuura (52 yo)

no data

Tenure


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: 4934 only recently listed within the past 12 months.


Top Shareholders

Company Information

Premier Anti-Aging Co., Ltd.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Premier Anti-Aging Co., Ltd.
  • Ticker: 4934
  • Exchange: TSE
  • Founded: 2009
  • Industry: Personal Products
  • Sector: Household
  • Market Cap: JP¥117.022b
  • Shares outstanding: 8.72m
  • Website: https://www.p-antiaging.co.jp

Location

  • Premier Anti-Aging Co., Ltd.
  • Toranomon Hills Mori Tower
  • 8th Floor
  • Tokyo
  • 105-6308
  • Japan

Listings


Biography

Premier Anti-Aging Co., Ltd. engages in the planning, development, import/export, mail order, wholesale, and retail business of cosmetics and health foods. The company offers its cosmetic products under th...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/06/17 08:08
End of Day Share Price2021/06/17 00:00
EarningsN/A
Annual EarningsN/A


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.